GE HealthCare TechnologiesSTU:L0T +1.37%72 FCF Margin % is 2.18% as of Mar. 2026, which is 74% below its 10-year median of 8.32. GuruFocus rates STU:L0T with a GF Score™ of 72/100 and a GF Value™ of €74.58 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 66.75% on this metric.
The historical rank and industry rank for GE HealthCare Technologies's FCF Margin % or its related term are showing as below:
STU:L0T'
s FCF Margin % Range Over the Past 10 Years
Min: 7.2 Med: 8.32 Max: 9.97
Current: 7.2
During the past 7 years, the highest FCF Margin % of GE HealthCare Technologies was 9.97%. The lowest was 7.20%. And the median was 8.32%.
STU:L0T's FCF Margin % is ranked better than 66.75% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs STU:L0T: 7.20
GE HealthCare Technologies FCF Margin % Related Terms
GE HealthCare Technologies FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:L0T vs DXCM, STE, ZBH: FCF Margin % Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's FCF Margin % distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (STU:L0T) has a FCF Margin % of 2.18% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GE HealthCare Technologies and its competitors. This is 74% below median its historical median of 8.32. Over the past decade, GE HealthCare Technologies' FCF Margin % has ranged from 7.20 to 9.97. According to the industry distribution chart, GE HealthCare Technologies ranks #271 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 33.3%.
Is GE HealthCare Technologies' FCF Margin % too high?
GE HealthCare Technologies' current FCF Margin % of 2.18% is 74% below median its 10-year median of 8.32. Over the past 10 years, this metric has ranged from a low of 7.20 to a high of 9.97. Based on the distribution chart, GE HealthCare Technologies ranks #271 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' FCF Margin % compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #271 out of 815 companies for FCF Margin %. This puts GE HealthCare Technologies in the upper half of its industry. Historically, GE HealthCare Technologies' own FCF Margin % has ranged from 7.20 to 9.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current FCF Margin % is 2.18%, which is 74% below median its own 10-year median of 8.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €74.58, compared to a current price of €57.67 — trading 22.7% below its estimated fair value. The current FCF Margin % is 2.18%, which is 74% below median its 10-year median of 8.32. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current FCF Margin % is 2.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of €57.67 is trading 22.7% below its estimated GF Value™ of €74.58.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for STU:L0T:
FCF Margin %: 2.18% (74% below median its 10-year median of 8.32)
GF Value™: €74.58 vs. price of €57.67 (22.7% below fair value)
No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score
Get the complete analysis for STU:L0T
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L0T has been successfully added to your 
